Investments
72Funds
2About Med-Fine Capital
Med-Fine Capital makes venture capital and private equity investments in the fields of biosciences and healthcare, particularly focusing on promising early-phase and growth-stage companies.
Want to inform investors similar to Med-Fine Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Med-Fine Capital News
May 24, 2023
Larkspur Biosciences, a Watertown, MA-based biotechnology company building immunotherapies for cancer, raised $35.5M in funding.The round was led by Polaris Innovation Fund, 3E Bioventures Capital, and Takeda Ventures.Other investors included Creacion Ventures, Med-Fine Capital and Cornell University.Lewis Cantley, Nathanael Gray, and Vijay K. Kuchroo and led by CEO Catherine Sabatos-Peyton, Larkspur provides LarkX, a proprietary platform that leverages patient genetics and immune phenotypes, applying bioinformatics and complex in vitro models, to discover critical immune barriers.Armed with insights into evasion signatures that can be shared by different cancer indications, it offers the opportunity to address multiple types of cancer. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
Med-Fine Capital Investments
72 Investments
Med-Fine Capital has made 72 investments. Their latest investment was in Larkspur Biosciences as part of their Series A on May 5, 2023.
Med-Fine Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/23/2023 | Series A | Larkspur Biosciences | Yes | 3 | ||
1/12/2023 | Series A - II | Med-Vision | No | 3 | ||
9/9/2022 | Series A | Leadinno Medical Valley | $14.5M | No | 5 | |
9/7/2022 | Seed - II | |||||
7/26/2022 | Seed VC - II |
Date | 5/23/2023 | 1/12/2023 | 9/9/2022 | 9/7/2022 | 7/26/2022 |
|---|---|---|---|---|---|
Round | Series A | Series A - II | Series A | Seed - II | Seed VC - II |
Company | Larkspur Biosciences | Med-Vision | Leadinno Medical Valley | ||
Amount | $14.5M | ||||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 3 | 3 | 5 |
Med-Fine Capital Fund History
2 Fund Histories
Med-Fine Capital has 2 funds, including 苏州一元幂方医药创业投资合伙企业 (Suzhou Yiyuan Mifang Pharmaceutical Venture Capital Partnership).
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
苏州一元幂方医药创业投资合伙企业 (Suzhou Yiyuan Mifang Pharmaceutical Venture Capital Partnership) | |||||
德州两仪幂方康健创业投资合伙企业 (Dezhou Liangyi Mifang Health Venture Capital Partnership) |
Closing Date | ||
|---|---|---|
Fund | 苏州一元幂方医药创业投资合伙企业 (Suzhou Yiyuan Mifang Pharmaceutical Venture Capital Partnership) | 德州两仪幂方康健创业投资合伙企业 (Dezhou Liangyi Mifang Health Venture Capital Partnership) |
Fund Type | ||
Status | ||
Amount | ||
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
